Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Amyotrophic lateral sclerosis (ALS) is a degenerative disorder of motor neurons in the cortex, brainstem and spinal cord. Its cause is unknown and it is uniformly fatal, typically within five years. About 10% of cases are inherited as an autosomal dominant trait, with high penetrance after the sixth decade. In most instances, sporadic and autosomal dominant familial ALS (FALS) are clinically similar. We have previously shown that in some but not all FALS pedigrees the disease is linked to a genetic defect on chromosome 21q (refs 8, 9). Here we report tight genetic linkage between FALS and a gene that encodes a cytosolic, Cu/Zn-binding superoxide dismutase (SOD1), a homodimeric metalloenzyme that catalyzes the dismutation of the toxic superoxide anion O2.- to O2 and H2O2 (ref. 10). Given this linkage and the potential role of free radical toxicity in other neurodenegerative disorders, we investigated SOD1 as a candidate gene in FALS. We identified 11 different SOD1 missense mutations in 13 different FALS families.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Long-standing associations of some forms of ALS with mutations in genes coding for superoxide dismutase 1”
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Orita, M., Suzuki, Y., Sekiya, T., & Hayashi, K. (1989) · Genomics · doi:10.1016/0888-7543(89)90129-8 · Cited by 3,434
DNA damage and oxygen radical toxicity
Imlay, J. A., & Linn, S. (1988) · Science · doi:10.1126/science.3287616 · Cited by 1,974
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Functional inactivation of genes by dominant negative mutations
Herskowitz, I. (1987) · Nature · doi:10.1038/329219a0 · Cited by 1,160
Carlioz, A., & Touati, D. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04256.x · Cited by 784
Centre d'Etude du polymorphisme humain (CEPH): Collaborative genetic mapping of the human genome
Dausset, J., Cann, H., Cohen, D., Lathrop, M., Lalouel, J.-M., & White, R. (1990) · Genomics · doi:10.1016/0888-7543(90)90491-c · Cited by 575
Copper,zinc superoxide dismutase is primarily a cytosolic protein in human cells.
Crapo, J. D., Oury, T., Rabouille, C., Slot, J. W., & Chang, L. Y. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10405 · Cited by 503
Richardson, J., Thomas, K. A., Rubin, B. H., & Richardson, D. C. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.4.1349 · Cited by 403
Familial adult motor neuron disease: amyotrophic lateralsclerosis
(1986) · Neurology · doi:10.1212/wnl.36.4.511 · Cited by 401
Self-citation
Research works printed but not linked: 7
- Kurland, L. T. Proc. Staff Meet Mayo Clin. 32, 449–462 (1957).
- Swerts, L. & Van Den Bergh, R. J. J. genet. Hum. 24, 247–255 (1976).
- Fridovich, I. Adv. Enzym. 58, 61–97 (1986).
- Ott, J. Am. hum. Genet. 28, 528–529 (1976).
- Ott, J. Analysis of Human Genetics 203–216 (Johns Hopkins Univ. Press, Baltimore, 1991).
- Hallewell, R. A. et al. in Superoxide Dismutase in Chemistry, Biology and Medicine (ed. Rotilio, G.) 249–256 (Elsevier, 1986).
- Muller, H. in Sixth internat. Congr. Genetics (ed. Jones, D.) 213–255 (Brooklyn Botanic Gardens, Menasha, 1932).
Cited by
Items 701–800 of 1,128
Reactive oxygen/nitrogen species and their functional correlations in neurodegenerative diseases
Ramalingam, M., & Kim, S.-J. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-011-0758-7 · Cited by 193
“There are three different isoforms of the SOD enzyme: copper/zinc SOD (SOD1), Manganese SOD (SOD2) and extra-cellular SOD (SOD3) (Jackson-Lewis et al. 2011; Halliwell 2006).”
InfluentialActivation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice
Chiu, I. M., Phatnani, H., Kuligowski, M., Tapia, J. C., Carrasco, M. A., Zhang, M., Maniatis, T., & Carroll, M. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911405106 · Cited by 194
“Although the majority of cases are sporadic (90%), the most common form of familial ALS is linked to mutations in the Cu/Zn superoxide dismutase 1 (SOD1) gene (1).”
BackgroundContribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis
Daoud, H., Valdmanis, P. N., Kabashi, E., Dion, P., Dupré, N., Camu, W., Meininger, V, & Rouleau, G. A. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062463 · Cited by 194
“Mutations in the Cu/Zn superoxide dismutase 1 (SOD1) gene account for approximately 12–20% of familial ALS cases.(3) However, mutations in other genes have since been reported for ALS, including VAPB, ALS2, SETX, DCTN1 and ANG, which together account for only a small proportion of ALS cases.”
BackgroundSelf-citationALS: A bucket of genes, environment, metabolism and unknown ingredients
Zufiría, M., Gil-Bea, F. J., Fernández-Torrón, R., Poza, J. J., Muñoz-Blanco, J. L., Rojas-García, R., Riancho, J., & López de Munain, A. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.05.004 · Cited by 194
Lessons from models of SOD1-linked familial ALS
Bendotti, C., & Carrì, M. T. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.06.009 · Cited by 194
Lindberg, M. J., Tibell, L., & Oliveberg, M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262527099 · Cited by 193
Turner, B. J., Atkin, J. D., Farg, M. A., Zang, D. W., Rembach, A., Lopes, E. C., Patch, J. D., Hill, A. F., & Cheema, S. S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4253-04.2005 · Cited by 193
The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
Berning, B. A., & Walker, A. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00335 · Cited by 193
“Mutations to the SOD1 gene were the first reported cause of ALS (Rosen et al., 1993).”
BackgroundAngelov, D. N., Waibel, S., Guntinas-Lichius, O., Lenzen, M., Neiss, W. F., Tomov, T. L., Yoles, E., Kipnis, J., Schori, H., Reuter, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530191100 · Cited by 193
Opportunities and challenges of pluripotent stem cell neurodegenerative disease models
Sandoe, J., & Eggan, K. (2013) · Nature Neuroscience · doi:10.1038/nn.3425 · Cited by 191
Graf, M., Ecker, D., Horowski, R., Kramer, B., Riederer, P., Gerlach, M., Hager, C., Ludolph, A. C., Kramer, B., Ecker, D., et al. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0220-1 · Cited by 192
Excitotoxicity and Amyotrophic Lateral Sclerosis
van Cutsem, P., Dewil, M., Robberecht, W., & van den Bosch, L. (2005) · Neurodegenerative Diseases · doi:10.1159/000089620 · Cited by 192
“Amyotrophic Lateral Sclerosis Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disease characterized by progressive loss of upper motor neurons in the motor cortex and of lower motor neurons in the brainstem and spinal cord. ALS typically affects adults in mid-life, with an incidence of 1–2/100,0…”
BackgroundGidalevitz, T., Krupinski, T., Garcia, S., & Morimoto, R. I. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000399 · Cited by 192
“contributing about 20% of those [1,2].”
FUS Interacts with HSP60 to Promote Mitochondrial Damage
Deng, J., Yang, M., Chen, Y., Chen, X., Liu, J., Sun, S., Cheng, H., Li, Y., Bigio, E. H., Mesulam, M., et al. (2015) · PLOS Genetics · doi:10.1371/journal.pgen.1005357 · Cited by 192
The kinetics of the oxidation of l-ascorbic acid by peroxynitrite
Bartlett, D., Church, D. F., Bounds, P. L., & Koppenol, W. H. (1995) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(94)e0133-4 · Cited by 192
Guareschi, S., Cova, E., Cereda, C., Ceroni, M., Donetti, E., Bosco, D. A., Trotti, D., & Pasinelli, P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115402109 · Cited by 189
“Disease-causing mutations in various genes have been identified (4–6); abundant among these are mutations in the gene encoding for Cu/Zn superoxide dismutase (SOD1) (7).”
FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis
Kabashi, E., Bercier, V., Lissouba, A., Liao, M., Brustein, E., Rouleau, G. A., & Drapeau, P. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002214 · Cited by 190
Self-citationSOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization
Banci, L., Bertini, I., Boca, M., Girotto, S., Martinelli, M., Valentine, J. S., & Vieru, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001677 · Cited by 191
Bendotti, C., Calvaresi, N., Chiveri, L., Prelle, A., Moggio, M., Braga, M., Silani, V., & De Biasi, S. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00627-x · Cited by 191
Neurofilament subunit NF-H modulates axonal diameter by selectively slowing neurofilament transport.
Marszalek, J. R., Williamson, T. L., Lee, M. K., Xu, Z., Hoffman, P. N., Becher, M. W., Crawford, T. O., & Cleveland, D. W. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.3.711 · Cited by 191
Common molecular signature in SOD1 for both sporadic and familial amyotrophic lateral sclerosis
Gruzman, A., Wood, W. L., Alpert, E., Prasad, M. D., Miller, R. G., Rothstein, J. D., Bowser, R., Hamilton, R., Wood, T. D., Cleveland, D. W., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705044104 · Cited by 189
Strange, R. W., Antonyuk, S. V., Hough, M. A., Doucette, P. A., Valentine, J. S., & Hasnain, S. S. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.11.081 · Cited by 190
Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism
Ferraiuolo, L., Meyer, K., Sherwood, T. W., Vick, J., Likhite, S., Frakes, A., Miranda, C. J., Braun, L., Heath, P. R., Pineda, R., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607496113 · Cited by 189
“Mutations in superoxide dismutase 1 (SOD1) (1), TAR DNA-binding protein 43 (TDP43) (2, 3), Fused in sarcoma (FUS) (4, 5), and hexanucleotide repeat expansions in chromosome 9 ORF 72 (C9orf72) (6, 7) are responsible for about 65% of these cases.”
BackgroundChance, P. F., Rabin, B. A., Ryan, S. G., Ding, Y., Scavina, M., Crain, B., Griffin, J. W., & Cornblath, D. R. (1998) · The American Journal of Human Genetics · doi:10.1086/301769 · Cited by 191
Autophagy and ALS: mechanistic insights and therapeutic implications
Chua, J. P., De Calbiac, H., Kabashi, E., & Barmada, S. J. (2022) · Autophagy · doi:10.1080/15548627.2021.1926656 · Cited by 189
“superoxide dismutase 1 [294,295], represent the second most common cause of familial ALS in Europeans and the most”
BackgroundGene therapy for ALS: A review
Amado, D. A., & Davidson, B. L. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.008 · Cited by 184
“Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS.”
BackgroundInfluentialThe use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies
Gurney, M. E. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00247-5 · Cited by 188
Ethanol‐induced teratogenesis: Free radical damage as a possible mechanism
Kotch, L. E., Chen, S., & Sulik, K. K. (1995) · Teratology · doi:10.1002/tera.1420520304 · Cited by 189
Renal antioxidant enzymes: Their regulation and function
Ichikawa, I., Kiyama, S., & Yoshioka, T. (1994) · Kidney International · doi:10.1038/ki.1994.1 · Cited by 189
Hottinger, A. F., Azzouz, M., Déglon, N., Aebischer, P., & Zurn, A. D. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-15-05587.2000 · Cited by 188
“With the exception of mutations in the gene for superoxide dismutase I (SOD) found in ;2% of all cases (Rosen, 1993), the etiology of the disease is still unknown and no treatment is currently available.”
BackgroundLafon-Cazal, M., Culcasi, M., Gaven, F., Pietri, S., & Bockaert, J. (1993) · Neuropharmacology · doi:10.1016/0028-3908(93)90020-4 · Cited by 189
Canto, M. C. D., & Gurney, M. E. (1997) · Acta Neuropathologica · doi:10.1007/s004010050650 · Cited by 188
“About 10‐15% of familial cases are due to a number of different missense mutations in the gene for Cu,Zn superoxide dismutase (SOD1) [1, 11, 13, 24, 33, 34, 37 ], an enzyme which is important in the dismutation of superoxide anion to H 2O2 [3, 22, 41, 46].”
BackgroundSequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin‐independent mechanism
Gal, J., Ström, A., Kwinter, D. M., Kilty, R., Zhang, J., Shi, P., Fu, W., Wooten, M. W., & Zhu, H. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06388.x · Cited by 187
Brettschneider, J., Van Deerlin, V. M., Robinson, J. L., Kwong, L., Lee, E. B., Ali, Y. O., Safren, N., Monteiro, M. J., Toledo, J. B., Elman, L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0970-z · Cited by 186
“Over ten genes have been found to harbor mutations that cause fALS, with mutations in SOD1, encoding the Cu/Zn superoxide dismutase, TARDBP, fused in sarcoma (FUS) and the optineurin (OPTN) gene accounting for *30 % of these cases [9, 19, 28, 43, 47, 51, 57].”
BackgroundFamilial Amyotrophic Lateral Sclerosis
Boylan, K. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.001 · Cited by 185
Yamaguchi-Iwai, Y., Serpe, M., Haile, D., Yang, W., Kosman, D. J., Klausner, R. D., & Dancis, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17711 · Cited by 187
Randomized, Double-Blind, Controlled Trial of Acetylcysteine in Amyotrophic Lateral Sclerosis
Louwerse, E. S., Weverling, G. J., Bossuyt, P. M. M., Meyjes, F. E. P., & de Jong, J. M. B. V. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540300031009 · Cited by 188
Using Knockout and Transgenic Mice to Study Neurophysiology and Behavior
PICCIOTTO, M. R., & WICKMAN, K. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.1131 · Cited by 186
Protein Homeostasis in Models of Aging and Age-Related Conformational Disease
Kikis, E. A., Gidalevitz, T., & Morimoto, R. I. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-7002-2_11 · Cited by 185
CHIP promotes proteasomal degradation of familial ALS‐linked mutant SOD1 by ubiquitinating Hsp/Hsc70
Urushitani, M., Kurisu, J., Tateno, M., Hatakeyama, S., Nakayama, K., Kato, S., & Takahashi, R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02486.x · Cited by 186
Vajragupta, O., Boonchoong, P., Watanabe, H., Tohda, M., Kummasud, N., & Sumanont, Y. (2003) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.09.011 · Cited by 186
Drosophila melanogaster as a Model Organism of Brain Diseases
Jeibmann, A., & Paulus, W. (2009) · International Journal of Molecular Sciences · doi:10.3390/ijms10020407 · Cited by 185
“Earlier attempts to model ALS yielded confusing results as expression of hSOD1 transgene and human mutated Gly41-to-Ser SOD in motorneurons by D42-GAL4 led to increased longevity and could rescue the lifespan of a dSod null mutant with shortened lifespan [105,106].”
BackgroundInfluentialResveratrol: A Natural Compound with Pharmacological Potential in Neurodegenerative Diseases
Rocha‐González, H. I., Ambriz‐Tututi, M., & Granados‐Soto, V. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00045.x · Cited by 186
“Only 2% of all cases are due to a mutation in the enzyme superoxide dismutase 1 [56]; however, the most cases are sporadic and their mechanisms are unknown.”
BackgroundInduced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises
Marchetto, M. C., Brennand, K. J., Boyer, L. F., & Gage, F. H. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr336 · Cited by 185
“More then 10 different genes have been implicated in ALS, including superoxide dismutase 1 (SOD1, ALS1) (11) and vamp-associated protein B/C (VAPB, ALS8) (12).”
BackgroundAutophagic and endo-lysosomal dysfunction in neurodegenerative disease
Malik, B. R., Maddison, D. C., Smith, G. A., & Peters, O. M. (2019) · Molecular Brain · doi:10.1186/s13041-019-0504-x · Cited by 184
PHARMACOLOGY OF NEUROTROPHIC FACTORS
Hefti, F. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.239 · Cited by 186
Heterozygous R1101K mutation of the DCTN1 gene in a family with ALS and FTD
Münch, C., Rosenbohm, A., Sperfeld, A., Uttner, I., Reske, S., Krause, B. J., Sedlmeier, R., Meyer, T., Hanemann, C. O., Stumm, G., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20631 · Cited by 186
“For familial ALS, seen in approximately 10% of ALS patients, two disease-causing genes have been identified previously, the copper/zinc superoxide dismutase (SOD1) gene and the ALS2 (alsin) gene encoding a putative GTPase regulator.(7,8) A missense mutation in the p150 subunit of the axonal transport protein dynactin…”
BackgroundIn vivo genome editing improves motor function and extends survival in a mouse model of ALS
Gaj, T., Ojala, D. S., Ekman, F. K., Byrne, L. C., Limsirichai, P., & Schaffer, D. V. (2017) · Science Advances · doi:10.1126/sciadv.aar3952 · Cited by 185
“Dominant mutations in the Cu-Zn superoxide dismutase 1 (SOD1) (3) gene account for ~20%of familial forms of the disease and~2%of all cases.”
BackgroundThe evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS)
Strong, M. J. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.09.029 · Cited by 183
“1 SOD1 Adult Dominant and recessive none [150]”
Hyperexcitability of Cultured Spinal Motoneurons From Presymptomatic ALS Mice
Kuo, J. J., Schonewille, M., Siddique, T., Schults, A. N. A., Fu, R., Bär, P. R., Anelli, R., Heckman, C. J., & Kroese, A. B. A. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00665.2003 · Cited by 185
Self-citationLanders, J. E., Melki, J., Meininger, V., Glass, J. D., van den Berg, L. H., van Es, M. A., Sapp, P. C., van Vught, P. W. J., McKenna-Yasek, D. M., Blauw, H. M., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812937106 · Cited by 185
“Dupuis L, et al. (2000) Differential screening of mutated SOD1 transgenic mice reveals early up-regulation of a fast axonal transport component in spinal cord motor neurons.”
BackgroundSelf-citationAlpha synuclein in neurodegenerative disorders: Murderer or accomplice?
Mezey, E., Dehejia, A., Harta, G., Papp, M. I., Polymeropoulos, M. H., & Brownstein, M. J. (1998) · Nature Medicine · doi:10.1038/nm0798-755 · Cited by 184
Ellerby, H. M., Martin, S. J., Ellerby, L. M., Naiem, S. S., Rabizadeh, S., Salvesen, G. S., Casiano, C. A., Cashman, N. R., Green, D. R., & Bredesen, D. E. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-16-06165.1997 · Cited by 185
“For example, mutations of sod1, which encodes copper/ zinc superoxide dismutase (CuZnSOD), are associated with familial amyotrophic lateral sclerosis (Rosen et al., 1993), and these”
BackgroundOxidative Damage to RNA in Aging and Neurodegenerative Disorders
Nunomura, A., Moreira, P. I., Castellani, R. J., Lee, H.-G., Zhu, X., Smith, M. A., & Perry, G. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9331-x · Cited by 183
“A strong genetic link between oxidative damage and neurodegeneration has been suggested by the finding that about 20 % of patients with familial ALS present a mutation in SOD1, a metalloenzyme that catalyzes the dismutation of the toxic superoxide (O2 ) to hydrogen peroxide (H2O2) (Rosen et al. 1993).”
BackgroundMetal ions as modulators of protein conformation and misfolding in neurodegeneration
Leal, S. S., Botelho, H. M., & Gomes, C. M. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.04.004 · Cited by 183
Mice lacking cytosolic copper/zinc superoxide dismutase display a distinctive motor axonopathy
Shefner, J. M., Reaume, A. G., Flood, D. G., Scott, R. W., Kowall, N. W., Ferrante, R. J., Siwek, D. F., Upton–Rice, M., & Brown, R. H. (1999) · Neurology · doi:10.1212/wnl.53.6.1239 · Cited by 183
Self-citationHerrmann, H., Hesse, M., Reichenzeller, M., Aebi, U., & Magin, T. M. (2002) · International Review of Cytology · doi:10.1016/s0074-7696(05)23003-6 · Cited by 184
Deletion of C9ORF72 Results in Motor Neuron Degeneration and Stress Sensitivity in C. elegans
Therrien, M., Rouleau, G. A., Dion, P. A., & Parker, J. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083450 · Cited by 183
“dismutase 1 (SOD1) [1] and thanks to recent genetic advances”
BackgroundSelf-citationKiaei, M., Petri, S., Kipiani, K., Gardian, G., Choi, D.-K., Chen, J., Calingasan, N. Y., Schafer, P., Muller, G. W., Stewart, C., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5253-05.2006 · Cited by 182
“A major discovery in the study of ALS was the finding of missense mutations in the enzyme copper–zinc superoxide dismutase (SOD1), which is associated with 15–20% of familial ALS cases (Rosen et al., 1993).”
BackgroundControl of Motoneuron Survival by Angiogenin
Kieran, D., Sebastia, J., Greenway, M. J., King, M. A., Connaughton, D., Concannon, C. G., Fenner, B., Hardiman, O., & Prehn, J. H. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3399-08.2008 · Cited by 182
“Although the specific etiology of ALS is largely unknown, 20% of familial ALS cases carry mutations in the gene encoding Cu/Zn superoxide dismutase-1 (SOD1) (Rosen et al., 1993).”
BackgroundLyons, T. J., Liu, H., Goto, J. J., Nersissian, A., Roe, J. A., Graden, J. A., Café, C., Ellerby, L. M., Bredesen, D. E., Gralla, E. B., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12240 · Cited by 182
Self-citationMechanisms of neurodegeneration in amyotrophic lateral sclerosis: Figure 1
Cluskey, S., & Ramsden, D. B. (2001) · Molecular Pathology · doi:10.1136/mp.54.6.386 · Cited by 182
Altered expression of bcl‐2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons
Mu, X., He, J., Anderson, D. W., Springer, J. E., & Trojanowski, J. Q. (1996) · Annals of Neurology · doi:10.1002/ana.410400307 · Cited by 182
Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders
Salvadores, N., Sanhueza, M., Manque, P., & Court, F. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00451 · Cited by 182
“For example, In the case of ALS, the first genetic link to the disease was made with the discovery of mutations in superoxide dismutase SOD1, an enzyme that catalyzes the conversion of the toxic O−2 anions into O2 and H2O2 (Rosen et al., 1993).”
BackgroundRole of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS
Karch, C. M., Prudencio, M., Winkler, D. D., Hart, P. J., & Borchelt, D. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902505106 · Cited by 182
Martin, L. J., Gertz, B., Pan, Y., Price, A. C., Molkentin, J. D., & Chang, Q. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.02.015 · Cited by 180
“Mutations in the SOD1 gene account for∼20% of all fALS cases (∼2% of all ALS cases) (Deng et al., 1993; Rosen et al., 1993).”
BackgroundZhang, F., Ström, A.-L., Fukada, K., Lee, S., Hayward, L. J., & Zhu, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609743200 · Cited by 179
Hottinger, A. F., Fine, E. G., Gurney, M. E., Zurn, A. D., & Aebischer, P. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01511.x · Cited by 180
Cytokine upregulation in a murine model of familial amyotrophic lateral sclerosis
Elliott, J. L. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00242-x · Cited by 181
Response of Glial Cells to Ischemia: Roles of Reactive Oxygen Species and Glutathione
JUURLINK, B. H. J. (1997) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(96)00005-x · Cited by 180
Acsadi, G., Anguelov, R. A., Yang, H., Toth, G., Thomas, R., Jani, A., Wang, Y., Ianakova, E., Mohammad, S., Lewis, R. A., et al. (2002) · Human Gene Therapy · doi:10.1089/104303402753812458 · Cited by 181
The role of mitochondria in inherited neurodegenerative diseases
Kwong, J. Q., Beal, M. F., & Manfredi, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03990.x · Cited by 180
Kato, S., Takikawa, M., Nakashima, K., Hirano, A., Cleveland, D. W., Kusaka, H., Shibata, N., Kato, M., Nakano, I., & Ohama, E. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515160 · Cited by 180
Ratovitski, T., Corson, L. B., Strain, J., Wong, P., Cleveland, D. W., Culotta, V. C., & Borchelt, D. R. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.8.1451 · Cited by 180
“Although the etiology of the more common ‘sporadic’ form of ALS is not well defined, mutations in sod1 have been associated with a subset of inherited cases (3, 4 ).”
BackgroundTortarolo, M., Veglianese, P., Calvaresi, N., Botturi, A., Rossi, C., Giorgini, A., Migheli, A., & Bendotti, C. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00022-8 · Cited by 180
The endocannabinoid system as a target for the treatment of neurodegenerative disease
Scotter, E. L., Abood, M. E., & Glass, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00735.x · Cited by 179
“Endocannabinoid changes in animal models of ALS Mutations in Cu/Zn superoxide dismutase (hSOD1) are the primary cause of up to 20% of familial ALS cases (Rosen et al., 1993).”
Walker, A. K., Farg, M. A., Bye, C. R., McLean, C. A., Horne, M. K., & Atkin, J. D. (2010) · Brain · doi:10.1093/brain/awp267 · Cited by 177
“Mutations in the gene encoding superoxide dismutase 1 (SOD1) account for a small proportion of cases of ALS (Rosen, 1993; Selverstone Valentine et al., 2005), but produce a disease that is clinically and pathologi- cally similar to sporadic ALS.”
Pathogenesis of amyotrophic lateral sclerosis
Morgan, S., & Orrell, R. W. (2016) · British Medical Bulletin · doi:10.1093/bmb/ldw026 · Cited by 177
“SOD1 Copper zinc superoxide dismutase (SOD1) was the first genetic cause of ALS to be identified, in 1993.(14) Mutations are commonly estimated to be present in around 20% of familial patients, and 1% of apparently sporadic.”
BackgroundRossi, D. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.04.003 · Cited by 177
An NMR View of Protein Dynamics in Health and Disease
Sekhar, A., & Kay, L. E. (2019) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-052118-115647 · Cited by 177
Project MinE ALS Sequencing Consortium (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0177-4 · Cited by 178
Zhang, Y., & Herman, B. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00349-9 · Cited by 178
Riluzole preserves motor function in a transgenic model of familial amyotrophic lateral sclerosis
Gurney, M. E., Fleck, T. J., Himes, C. S., & Hall, E. D. (1998) · Neurology · doi:10.1212/wnl.50.1.62 · Cited by 178
Gal, J., Ström, A.-L., Kilty, R., Zhang, F., & Zhu, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608787200 · Cited by 177
Expanded ATXN2 CAG repeat size in ALS identifies genetic overlap between ALS and SCA2
Van Damme, P., Veldink, J. H., van Blitterswijk, M., Corveleyn, A., van Vught, P. W. J., Thijs, V., Dubois, B., Matthijs, G., van den Berg, L. H., & Robberecht, W. (2011) · Neurology · doi:10.1212/wnl.0b013e31821f445b · Cited by 178
Portbury, S., & Adlard, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122506 · Cited by 175
Miyazaki, K., Fujita, T., Ozaki, T., Kato, C., Kurose, Y., Sakamoto, M., Kato, S., Goto, T., Itoyama, Y., Aoki, M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312389200 · Cited by 177
Characterization of a Pathway for Ciliary Neurotrophic Factor Signaling to the Nucleus
Bonni, A., Frank, D. A., Schindler, C., & Greenberg, M. E. (1993) · Science · doi:10.1126/science.7504325 · Cited by 176
Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS
Alexander, G. M., Erwin, K. L., Byers, N., Deitch, J. S., Augelli, B. J., Blankenhorn, E. P., & Heiman-Patterson, T. D. (2004) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.07.002 · Cited by 176
Parone, P. A., Da Cruz, S., Han, J. S., McAlonis-Downes, M., Vetto, A. P., Lee, S. K., Tseng, E., & Cleveland, D. W. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1119-12.2013 · Cited by 177
“Twenty percent of inherited ALS is caused by mutations in Cu/Zn superoxide dismutase (SOD1) (Rosen et al., 1993).”
BackgroundMicroglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
Lall, D., & Baloh, R. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90607 · Cited by 175
“…), FUS RNA binding protein ( FUS ), heterogeneous nuclear ribonucleoprotein A1 ( HNRNPA1 ), sequesto-some 1 ( SQSTM1 ), valosin-containing protein ( VCP ), optineurin ( OPTN ), TANK binding kinase 1 ( TBK1 ), ubiquilin 2 ( UBQLN2 ), and profilin 1 ( PFN1 ), have been identified in ALS (3–18).”
BackgroundTHE CYTOSKELETON AND DISEASE: Genetic Disorders of Intermediate Filaments
Fuchs, E. (1996) · Annual Review of Genetics · doi:10.1146/annurev.genet.30.1.197 · Cited by 175
Jeong, S. Y., Rathore, K. I., Schulz, K., Ponka, P., Arosio, P., & David, S. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5443-08.2009 · Cited by 174
Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
DeVos, S. L., & Miller, T. M. (2013) · Journal of Visualized Experiments · doi:10.3791/50326 · Cited by 165
IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients
Fiala, M., Chattopadhay, M., La Cava, A., Tse, E., Liu, G., Lourenco, E., Eskin, A., Liu, P. T., Magpantay, L., Tse, S., et al. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-76 · Cited by 174
“Less than 10% of ALS cases are familial (fALS) with 20% of these cases linked to various mutations in the Cu/Zn mutant superoxide dismutase 1 (SOD-1) gene [1].”
BackgroundMitochondrial Glutathione: Recent Insights and Role in Disease
Marí, M., de Gregorio, E., de Dios, C., Roca-Agujetas, V., Cucarull, B., Tutusaus, A., Morales, A., & Colell, A. (2020) · Antioxidants · doi:10.3390/antiox9100909 · Cited by 173
“Nearly 150 mutant forms of SOD1 have been identified in ALS patients, which are responsible for approximately 20% of all the inherited cases [117].”
BackgroundRastogi, S., Sharma, V., Bharti, P. S., Rani, K., Modi, G. P., Nikolajeff, F., & Kumar, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010440 · Cited by 174
Oxidative stress and apoptosis in neurodegeneration
Gorman, A. M., McGowan, A., O'Neill, C., & Cotter, T. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00097-4 · Cited by 174
Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS
Berger, M. M., Kopp, N., Vital, C., Redl, B., Aymard, M., & Lina, B. (2000) · Neurology · doi:10.1212/wnl.54.1.20 · Cited by 174
Nelson, L. M., McGuire, V., Longstreth, W. T., & Matkin, C. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010183 · Cited by 174
“Approximately 20 percent of patients with familial ALS have a missense mutation of the gene that codes for copper/zinc superoxide dismutase ( 32 ), an endogenous enzyme responsible for scavenging superoxide radicals in the body's tissues.”
Background
Metadata
- Authors
- Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., Rahmani, Z., Krizus, A., McKenna-Yasek, D., Cayabyab, A., Gaston, S. M., Berger, R., Tanzi, R. E., Halperin, J. J., Herzfeldt, B., Van den Bergh, R., Hung, W.-Y., Bird, T., Deng, G., Mulder, D. W., Smyth, C., Laing, N. G., Soriano, E., Pericak–Vance, M. A., Haines, J., Rouleau, G. A., Gusella, J. S., Horvitz, H. R., & Brown, R. H.
- Affiliations
- Massachusetts General Hospital (US)
- Northwestern University (US)
- Montreal General Hospital (CA)
- Howard Hughes Medical Institute (US)
- North Shore University Hospital (US)
- University of Washington (US)
- Mayo Clinic (US)
- ORCID
- Venue
- Nature
- Published
- 1993-03-01
- Volume
- 362
- Issue
- 6415
- Pages
- 59-62
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2096386031
- Cited by
- 7,062
- References
- 42
- Citations by year
- 2026: 137 · 2025: 154 · 2024: 201 · 2023: 185 · 2022: 254 · 2021: 259 · 2020: 295 · 2019: 205 · 2018: 258 · 2017: 248 · 2016: 242 · 2015: 248 · 2014: 262 · 2013: 264 · 2012: 315
- FWCI
- 174.77
- Type
- journal article
- Language
- en
- Update notices
- correction (1993-07-22)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- amyotrophic lateral sclerosis, familial ALS, SOD1, Cu/Zn superoxide dismutase, missense mutations, genetic linkage, chromosome 21q, autosomal dominant inheritance, free radical toxicity, candidate genes, motor neuron degeneration
- MeSH terms
- Amino Acid Sequence, Amyotrophic Lateral Sclerosis, Animals, Base Sequence, Codon, DNA, Exons, Humans, Isoenzymes, Lod Score, Molecular Sequence Data, Mutation, Nucleic Acid Conformation, Oligodeoxyribonucleotides, Polymorphism, Genetic, Repetitive Sequences, Nucleic Acid, Superoxide Dismutase, Genome, Human, Polymerase Chain Reaction, Sequence Homology, Amino Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.